LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.79 USD
-0.12 (-6.28%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $1.78 -0.01 (-0.56%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/27/2024
Time: -- |
6/2024 | $-0.33 | -15.15% |
Earnings Summary
For their last quarter, LAVA Therapeutics (LVTX) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.25 per share. This reflects a positive earnings surprise of 92.00%. Look out for LVTX's next earnings release expected on August 27, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year increase of 31.25%.
Earnings History
Price & Consensus
Zacks News for LVTX
LAVA Therapeutics N.V. (LVTX) Reports Q2 Loss, Tops Revenue Estimates
LVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services